Prestige Consumer Healthcare
PBH
#3935
Rank
S$3.90 B
Marketcap
S$79.34
Share price
0.95%
Change (1 day)
-29.48%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2025 (TTM): S$5.36

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is S$5.24. In 2024 the company made an earnings per share (EPS) of S$5.55 an increase over its 2023 EPS that were of S-$2.08.

EPS history for Prestige Consumer Healthcare from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$5.36-3.51%
2024S$5.55-367.08%
2023S-$2.08-138.33%
2022S$5.4211.7%
2021S$4.8613.6%
2020S$4.27-651.67%
2019S-$0.77-148.78%
2018S$1.59-83.29%
2017S$9.50437.23%
2016S$1.77-34.13%
2015S$2.6952.94%
2014S$1.76-8.11%
2013S$1.91
2011S$1.12

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
GlaxoSmithKline
GSK
S$4.64-11.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
S$2.22-57.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Rite Aid
RAD
S-$38.25-829.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$13.48 157.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
S$1.58-69.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
S$9.50 81.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Procter & Gamble
PG
S$9.08 73.15%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
S$0.52-90.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
S$8.28 57.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$10.40 98.45%๐Ÿ‡บ๐Ÿ‡ธ USA